J9321 Injection epcoritamab-bysp 0.16 milligrams
J-Codes
Also known as: epcoritamab, Epkinly
Injection of epcoritamab-bysp, 0.16 milligram. A bispecific B-cell engagement antibody (CD3 x CD20) for B-cell lymphomas.
Clinical Context
Used for relapsed/refractory B-cell non-Hodgkin lymphoma. Bispecific antibody engaging T-cells to CD20-positive B-cell lymphomas.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.